Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Caesalpinia
67%
Breast Cancer
62%
Malignant Neoplasm
53%
Amaryllidaceae
50%
Chemotherapy
34%
Melanoma
34%
Polyphenol
30%
Tumor Growth
29%
Doxorubicin
23%
Cancer Model
23%
Tumor Microenvironment
22%
Natural Product
21%
Leukemia
20%
Mouse
20%
Primary Tumor
20%
Acute Leukemia
18%
CD8 Antigen
18%
Clinical Trial
17%
Biological Activity
16%
Mouse Model
15%
Cytotoxicity
15%
Plant Extract
14%
Tannin
14%
Disease
14%
Caspase 3
13%
Adjuvant
12%
Antitumor Activity
12%
Flow Cytometry
11%
Breast Adenocarcinoma
11%
Myeloid Leukemia
11%
Cytokine
10%
Breast Carcinoma
9%
Drug
9%
Immunogenic Cell Death
8%
Gallic Acid
8%
IC50
8%
Breast Tumor
8%
Gamma Interferon
7%
Cytotoxicity
7%
Mutagenicity
7%
Genotoxicity
7%
Immunotherapy
7%
Tumor Necrosis Factor
6%
Clinical Study
6%
Antioxidant Capacity
6%
Drug Resistance
6%
Metastasis
5%
Reactive Oxygen Metabolite
5%
Immunostimulant
5%
Immunology and Microbiology
Immune Response
56%
T Cell
50%
Caesalpinia
46%
Cytotoxicity
42%
Tumor Cell
37%
Amaryllidaceae
35%
Myeloid
31%
Cytotoxic T-Cell
31%
CD8
28%
Epstein Barr Virus
27%
Tumor Volume
26%
Mouse
26%
Dendritic Cell
25%
Regulatory T Cell
25%
Human Immunodeficiency Virus
24%
Cell Line
24%
Extract
24%
Antineoplastic Activity
21%
Plant Extract
20%
Cell Death
17%
B Cell
15%
Mouse Model
14%
CD28
14%
Lymphocyte
14%
Tumor Necrosis Factor
13%
Immune System
12%
IC50
12%
Myeloid-Derived Suppressor Cell
11%
Melanoma Cell
11%
Heat Shock
11%
Microbial Diversity
11%
T Cell Receptor
11%
Glucose Transport
11%
CD4
10%
Adjuvant
10%
Leukemia Cell
10%
Energy Metabolism
10%
Autophagy
10%
Apoptosis
9%
Blood Plasma
9%
Mesenchymal Stem Cell
9%
Cancer Cell
9%
Human Immunodeficiency Virus 1
8%
Interleukin-6
8%
Immunosuppressive Drug
8%
Proinflammatory Cytokine
8%
Cell Population
8%
Cytotoxic T Cell
8%
Overall Survival
7%
CD8+ T Lymphocyte
7%
Medicine and Dentistry
Breast Cancer
51%
Immune Response
42%
Neoplasm
41%
In Vitro
27%
Tumor Microenvironment
27%
Cancer Model
21%
Primary Tumor
21%
Natural Product
20%
Programmed Cell Death
20%
Tumor Cell
18%
Cancer Stem Cell
18%
Cancer Cell
15%
Biological Activity
15%
Antineoplastic Activity
14%
Caspase 3
12%
Ex Vivo
12%
Tumor Progression
12%
Cell Death
12%
Metastatic Carcinoma
11%
Breast Adenocarcinoma
11%
Polyphenol
11%
T Lymphocyte
10%
DNA Fragmentation
10%
Cytotoxicity
10%
Leukemia
9%
Acute Leukemia
9%
Flow Cytometry
9%
Adenosine Triphosphate
9%
Tumor Metabolism
9%
Tumor Model
8%
Epstein Barr Virus
8%
Doxorubicin
8%
Cell Proliferation
8%
Clinical Trial
8%
Plant Extract
7%
Nodular Melanoma
7%
Breast Tumor
7%
Disease
6%
CD8+ T Lymphocyte
6%
Adjuvant
6%
Tannin
6%
Clinical Study
6%
Malignant Neoplasm
6%
Quality of Life
6%
Cancer Therapy
5%
Cancer Associated Fibroblast
5%
Melanoma Cell
5%
Prostaglandin Synthase Inhibitor
5%
Prostate Tumor
5%
Phosphotransferase
5%
